Literature DB >> 25658275

Increasing patient participation in drug development.

Paul Wicks1, Maria Lowe1, Susan Gabriel2, Slaven Sikirica2, Rahul Sasane2, Stephen Arcona2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25658275     DOI： 10.1038/nbt.3145

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  7 in total

1.  Patient-focused drug development programme takes first steps.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

2.  Social storm.

Authors:  Virginia Hughes
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908

3.  How the Patient-Centered Outcomes Research Institute is engaging patients and others in shaping its research agenda.

Authors:  Rachael Fleurence; Joe V Selby; Kara Odom-Walker; Gail Hunt; David Meltzer; Jean R Slutsky; Clyde Yancy
Journal:  Health Aff (Millwood)       Date:  2013-02       Impact factor: 6.301

4.  Do increases in patient activation result in improved self-management behaviors?

Authors:  Judith H Hibbard; Eldon R Mahoney; Ronald Stock; Martin Tusler
Journal:  Health Serv Res       Date:  2007-08       Impact factor: 3.402

5.  "If i wasn't this robust": patients' expectations and experiences at the Outcome Measures in Rheumatology Conference 2010.

Authors:  Maarten P T de Wit; Marije S Koelewijn-van Loon; Sarah Collins; Tineke A Abma; John Kirwan
Journal:  Patient       Date:  2013       Impact factor: 3.883

6.  Stakeholder engagement in patient-centered outcomes research: high-touch or high-tech?

Authors:  Danielle C Lavallee; Paul Wicks; Rafael Alfonso Cristancho; C Daniel Mullins
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2014-03-24       Impact factor: 2.217

7.  Could digital patient communities be the launch pad for patient-centric trial design?

Authors:  Paul Wicks
Journal:  Trials       Date:  2014-05-15       Impact factor: 2.279
  7 in total
  1 in total

1.  Involving Patient Groups in Drug Research: A Systematic Review of Reasons.

Authors:  Christoph Rach; Jan Lukas; Regina Müller; Matthias Sendler; Peter Simon; Sabine Salloch
Journal:  Patient Prefer Adherence       Date:  2020-03-12       Impact factor: 2.711
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.